These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


210 related items for PubMed ID: 17243640

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Central action of orexins on sympathetic outflow and cardiovascular function with a focus on the paraventricular nucleus of the hypothalamus].
    Kannan H, Shirasaka T, Watanabe S, Yu NS, Kuitake T, Takasaki M.
    Masui; 2007 Jan; 56(1):30-9. PubMed ID: 17243643
    [Abstract] [Full Text] [Related]

  • 3. Orexins in the regulation of the hypothalamic-pituitary-adrenal axis.
    Spinazzi R, Andreis PG, Rossi GP, Nussdorfer GG.
    Pharmacol Rev; 2006 Mar; 58(1):46-57. PubMed ID: 16507882
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Central and local (enteric) action of orexins.
    Korczynski W, Ceregrzyn M, Matyjek R, Kato I, Kuwahara A, Wolinski J, Zabielski R.
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 6():17-42. PubMed ID: 17228085
    [Abstract] [Full Text] [Related]

  • 6. Orexins (hypocretins) and adrenal function.
    Jöhren O, Brüggemann N, Dominiak P.
    Horm Metab Res; 2004 Jun; 36(6):370-5. PubMed ID: 15241726
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The physiological role of orexins.
    Martynska L, Wolinska-Witort E, Chmielowska M, Bik W, Baranowska B.
    Neuro Endocrinol Lett; 2005 Aug; 26(4):289-92. PubMed ID: 16135995
    [Abstract] [Full Text] [Related]

  • 11. Orexin/hypocretin modulation of the basal forebrain cholinergic system: insights from in vivo microdialysis studies.
    Fadel J, Frederick-Duus D.
    Pharmacol Biochem Behav; 2008 Aug; 90(2):156-62. PubMed ID: 18281084
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Non-sleep effects of hypocretin/orexin.
    Samson WK, Taylor MM, Ferguson AV.
    Sleep Med Rev; 2005 Aug; 9(4):243-52. PubMed ID: 16036174
    [Abstract] [Full Text] [Related]

  • 14. Adrenal expression of orexin receptor subtypes is differentially regulated in experimental streptozotocin induced type-1 diabetes.
    Jöhren O, Gremmels JA, Qadri F, Dendorfer A, Dominiak P.
    Peptides; 2006 Nov; 27(11):2764-9. PubMed ID: 16822588
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of orexin A and its receptor 1 in the bovine urethroprostatic complex.
    Russo F, Pavone LM, Tafuri S, Avallone L, Staiano N, Vittoria A.
    Anat Rec (Hoboken); 2008 Feb; 291(2):169-74. PubMed ID: 18213704
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The hypocretins: setting the arousal threshold.
    Sutcliffe JG, de Lecea L.
    Nat Rev Neurosci; 2002 May; 3(5):339-49. PubMed ID: 11988773
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of orexin signal in basal forebrain facilitates the emergence from sevoflurane anesthesia in rat.
    Dong H, Niu J, Su B, Zhu Z, Lv Y, Li Y, Xiong L.
    Neuropeptides; 2009 Jun; 43(3):179-85. PubMed ID: 19464733
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.